| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 4780.49 | 99 |
| GSM780708 | Untreated after 4 days (C2_1) | 3188.96 | 99 |
| GSM780709 | Untreated after 4 days (C3_1) | 2958.95 | 99 |
| GSM780719 | Untreated after 4 days (C1_2) | 4570.57 | 99 |
| GSM780720 | Untreated after 4 days (C2_2) | 3590.39 | 99 |
| GSM780721 | Untreated after 4 days (C3_2) | 2984.24 | 99 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2488.16 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 3480.87 | 99 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2737.74 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2572.58 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 3421.44 | 99 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 3005.55 | 99 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 4291.63 | 99 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 3325.46 | 99 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 5316.97 | 99 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 3793.21 | 99 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 3425.99 | 99 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 4722.49 | 99 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 851.2 | 95 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1069.49 | 96 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2262.68 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 752.155 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1849.17 | 98 |